Metformin: Clinical Trials

2,015 trials of Metformin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1282 completed, 296 unknown, 139 terminated, 115 recruiting. 457 Phase 2, 438 Phase 3, 435 Phase 4, 423 Phase 1, 255 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 2457Completed 234, Unknown 69, Terminated 58, Recruiting 43, Active not recruiting 24, Withdrawn 20, Not yet recruiting 9
Phase 3438Completed 302, Unknown 57, Terminated 30, Recruiting 23, Active not recruiting 8, Not yet recruiting 8, Withdrawn 8, Enrolling by invitation 1, Suspended 1
Phase 4435Completed 272, Unknown 83, Terminated 25, Withdrawn 18, Recruiting 17, Not yet recruiting 11, Active not recruiting 6, Enrolling by invitation 3
Phase 1423Completed 327, Recruiting 24, Unknown 24, Terminated 16, Withdrawn 13, Active not recruiting 9, Not yet recruiting 9, Enrolling by invitation 1
Not applicable255Completed 143, Unknown 60, Not yet recruiting 13, Recruiting 11, Terminated 11, Withdrawn 9, Active not recruiting 5, Enrolling by invitation 3
Early Phase 152Completed 27, Unknown 8, Recruiting 6, Terminated 5, Active not recruiting 2, Enrolling by invitation 2, Not yet recruiting 1, Withdrawn 1

Follow Metformin: new trials by email Literature Review of Metformin trials Research Report on Metformin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
Metformin - Chronic Obstructive Pulmonary Disease (COPD)
Phase 1Not yet recruitingDuke University452027-02-012026-11-03
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
Metformin - Psychosis, Cannabis Use
Phase 4Not yet recruitingNova Scotia Health Authority242027-02-012026-11-10
Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer
LNG-IUS: levonorgestrel intrauterine system, Metformin, Canagliflozin - Endometrioid Endometrial Cancer, Atypical Endometrial Hyperplasia
Phase 2Not yet recruitingWang Yingmei1022027-01-012026-10-22
Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High - Type 2 Diabetes, High Blood Pressure
Phase 1 / Phase 2WithdrawnARKAY Therapeutics2026-12-102026-07-16
Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes
Sotagliflozin, Empagliflozin (oral), Metformin - Type 2 Diabetes Mellitus (DM)
Phase 4Not yet recruitingAllied Hospital Faisalabad1402026-12-012026-11-16
Henagliflozin on Myocardial Fibrosis in Obese Patients
Henagliflozin 10 mg, Metformin - Myocardial Fibrosis, Obesity
Not applicableNot yet recruitingJing Ma1002026-12-012026-11-19
Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Therapy
Fuling Yunhua Granules, Dihuang Baoyuan Granules, Fuling Yunhua Granules Matched Placebo - Diabetes Mellitus, Type 2
Phase 2Not yet recruitingBeijing Supreme Life Pharmaceutical Technology Co., Ltd.1502026-11-202026-11-10
An Evaluation of the Potential for VH4011499 Drug-drug-interactions
VH4011499, Ritonavir, Efavirenz - HIV Infections
Phase 1Not yet recruitingViiV Healthcare752026-11-162026-11-16
Metformin and ACLR Muscle Recovery
Metformin, Placebo - Atrophy, Inflammation
Early Phase 1Not yet recruitingUniversity of Utah402026-11-012026-07-13
DDI Study of ECC0509 With Metformin, Midazolam, and Caffeine
ECC0509, Metformin, Caffeine - Steatohepatitis, Nonalcoholic, Osteo Arthritis
Phase 1Not yet recruitingEccogene402026-11-012026-10-14
Efficacy of Topical Metformin 30% Versus Minoxidil 5% in the Treatment of Alopecia Areata : Comparative Study
Metformin 30% Topical Lotion, Minoxidil 5 % Topical Spray - Alopecia Areata(AA)
Not applicableRecruitingSohag University602026-10-292026-11-19
Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma
Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma)
Phase 4Enrolling by invitationSameh Sarsik802026-10-252026-10-27
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Topical anti-aging peptide serum - Aging
Early Phase 1Enrolling by invitationFrontiers in Bioscience Research Institute and Aging482026-10-212026-10-22
Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia
Metformin, Naproxen Sodium - Fanconi Anemia, Head and Neck Cancer
Phase 1RecruitingRockefeller University802026-10-142026-10-28
Cardioprotective Effect of Empagliflozin in Breast Cancer Patients
Empagliflozin (EMPA), Metformin - Empgliflozin Cardioprotective Effect
Phase 3Not yet recruitingTanta University1502026-10-012026-09-24
Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD
Metformin + Dapagliflozin, Metformin - Type 2 Diabetes, Metabolic Dysfunction-Associated Steatotic Liver Disease
Not applicableNot yet recruitingThe 95th Hospital of Putian,Putian, Fujian, China842026-10-012026-08-21
Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
Metformin, Matching Placebo - Idiopathic Pulmonary Fibrosis
Phase 3Not yet recruitingUniversity of Massachusetts, Worcester8002026-09-282026-09-08
Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects
VC005 and verapamil, VC005 and probenecid, VC005 and metformin - Healthy Adult Participants
Phase 1Not yet recruitingJiangsu vcare pharmaceutical technology co., LTD842026-09-202026-09-01
Efficacy of Vildagliptin Versus Metformin in Patients With Polycystic Ovary Syndrome
Metformin, Vildagliptin (Galvus) - Poly Cystic Ovary Syndrome
Phase 2 / Phase 3Not yet recruitingTanta University702026-09-202026-09-21
A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults
Itraconazole, Rifampicin, Omeprazole - Healthy Subjects
Phase 1Not yet recruitingInventisBio Co., Ltd602026-09-162026-10-15

Showing 20 of 2015. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (709)  ·  Diabetes Mellitus (227)  ·  Polycystic Ovary Syndrome (161)  ·  Insulin Resistance (152)  ·  Obesity (111)  ·  Prediabetic State (48)  ·  Diabetes, Gestational (46)  ·  Metabolic Syndrome (46)  ·  Breast Neoplasms (40)  ·  Dyslipidemias (31)  ·  Glucose Intolerance (31)  ·  Prostatic Neoplasms (31)  ·  Hyperglycemia (29)  ·  Non-alcoholic Fatty Liver Disease (29)  ·  Glucose Metabolism Disorders (25)

Sponsors

Merck Sharp & Dohme LLC (69)  ·  AstraZeneca (58)  ·  Sanofi (56)  ·  Novo Nordisk A/S (49)  ·  Boehringer Ingelheim (48)  ·  Takeda (25)  ·  GlaxoSmithKline (23)  ·  Eli Lilly and Company (21)  ·  Novartis Pharmaceuticals (19)  ·  Ain Shams University (17)  ·  Janssen Research & Development, LLC (17)  ·  Assiut University (15)  ·  M.D. Anderson Cancer Center (15)  ·  University of California, San Francisco (15)  ·  Cairo University (13)

Countries

United States (612)  ·  China (215)  ·  Canada (149)  ·  Germany (139)  ·  Mexico (134)  ·  South Korea (130)  ·  Egypt (124)  ·  Italy (98)  ·  India (88)  ·  United Kingdom (87)  ·  France (81)  ·  Russia (81)  ·  Poland (77)  ·  Spain (77)  ·  Brazil (60)

Top investigators

Stefano Palomba, MD (10)  ·  James D. Carlson,, Pharm.D, (7)  ·  James D Carlson, Pharm. D. (6)

Results publications

PMID 32501595, PMID 38837240, PMID 25504028, PMID 27402391, PMID 38770818, PMID 23010561, PMID 26580237, PMID 26691396, PMID 26894924, PMID 27033025, PMID 27161178, PMID 27977934, PMID 31606880, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382, PMID 32648108, PMID 32994091, PMID 34213819, PMID 37435938, PMID 39963952, PMID 21883806, PMID 22193143, PMID 22862847, PMID 23186975, PMID 23795975, PMID 24517339, PMID 26579834, PMID 27600862, PMID 29974618, PMID 42653697, PMID 19245711, PMID 19491536, PMID 19878259, PMID 21450987, PMID 21680990, PMID 22055210, PMID 24561125, PMID 24742013, PMID 24786834, PMID 24918789, PMID 25329038, PMID 25813214, PMID 26121561, PMID 26373629, PMID 27461213, PMID 28197834, PMID 28241822, PMID 28327140

NIH funding

2008 (13), 2015 (13), 2016 (12), 2014 (11), 2019 (8), 2009 (7), 2023 (7), 2018 (6), 2017 (5), 2005 (4), 2004 (3), P30CA023074 (3), P30CA060553 (3), 2025 (2), N01MH090001 (2)